238 related articles for article (PubMed ID: 9290705)
21. Expression of the mitogen-inducible gene-2 (mig-2) is elevated in human uterine leiomyomas but not in leiomyosarcomas.
Kato K; Shiozawa T; Mitsushita J; Toda A; Horiuchi A; Nikaido T; Fujii S; Konishi I
Hum Pathol; 2004 Jan; 35(1):55-60. PubMed ID: 14745725
[TBL] [Abstract][Full Text] [Related]
22. Uterine leiomyoma cytogenetics.
Nibert M; Heim S
Genes Chromosomes Cancer; 1990 May; 2(1):3-13. PubMed ID: 2278965
[TBL] [Abstract][Full Text] [Related]
23. Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical application.
Sato S; Maekawa R; Yamagata Y; Tamura I; Lee L; Okada M; Jozaki K; Asada H; Tamura H; Sugino N
Sci Rep; 2016 Aug; 6():30652. PubMed ID: 27498619
[TBL] [Abstract][Full Text] [Related]
24. Array comparative genomic hybridization analysis of uterine leiomyosarcoma.
Cho YL; Bae S; Koo MS; Kim KM; Chun HJ; Kim CK; Ro DY; Kim JH; Lee CH; Kim YW; Ahn WS
Gynecol Oncol; 2005 Dec; 99(3):545-51. PubMed ID: 16125217
[TBL] [Abstract][Full Text] [Related]
25. MED12 alterations in both human benign and malignant uterine soft tissue tumors.
Pérot G; Croce S; Ribeiro A; Lagarde P; Velasco V; Neuville A; Coindre JM; Stoeckle E; Floquet A; MacGrogan G; Chibon F
PLoS One; 2012; 7(6):e40015. PubMed ID: 22768200
[TBL] [Abstract][Full Text] [Related]
26. DNA copy number changes in gastrointestinal stromal tumors--a distinct genetic entity.
el-Rifai W; Sarlomo-Rikala M; Andersson LC; Miettinen M; Knuutila S
Ann Chir Gynaecol; 1998; 87(4):287-90. PubMed ID: 9891767
[TBL] [Abstract][Full Text] [Related]
27. Genomic alterations in uterine leiomyosarcomas: potential markers for clinical diagnosis and prognosis.
Hu J; Khanna V; Jones M; Surti U
Genes Chromosomes Cancer; 2001 Jun; 31(2):117-24. PubMed ID: 11319799
[TBL] [Abstract][Full Text] [Related]
28. Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas.
Conconi D; Redaelli S; Lissoni AA; Cilibrasi C; Perego P; Gautiero E; Sala E; Paderno M; Dalprà L; Landoni F; Lavitrano M; Roversi G; Bentivegna A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557274
[TBL] [Abstract][Full Text] [Related]
29. Fumarase-deficient Uterine Leiomyomas: An Immunohistochemical, Molecular Genetic, and Clinicopathologic Study of 86 Cases.
Miettinen M; Felisiak-Golabek A; Wasag B; Chmara M; Wang Z; Butzow R; Lasota J
Am J Surg Pathol; 2016 Dec; 40(12):1661-1669. PubMed ID: 27454940
[TBL] [Abstract][Full Text] [Related]
30. Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas.
Mittal KR; Chen F; Wei JJ; Rijhvani K; Kurvathi R; Streck D; Dermody J; Toruner GA
Mod Pathol; 2009 Oct; 22(10):1303-11. PubMed ID: 19633649
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of the c-myc proto-oncogene occurs frequently in uterine sarcomas.
Jeffers MD; Richmond JA; Macaulay EM
Mod Pathol; 1995 Sep; 8(7):701-4. PubMed ID: 8539225
[TBL] [Abstract][Full Text] [Related]
32. Different patterns of DNA copy number changes in gastrointestinal stromal tumors, leiomyomas, and schwannomas.
Sarlomo-Rikala M; El-Rifai W; Lahtinen T; Andersson LC; Miettinen M; Knuutila S
Hum Pathol; 1998 May; 29(5):476-81. PubMed ID: 9596271
[TBL] [Abstract][Full Text] [Related]
33. Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma.
Zhang P; Zhang C; Hao J; Sung CJ; Quddus MR; Steinhoff MM; Lawrence WD
Hum Pathol; 2006 Oct; 37(10):1350-6. PubMed ID: 16949924
[TBL] [Abstract][Full Text] [Related]
34. Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions.
Croce S; Ribeiro A; Brulard C; Noel JC; Amant F; Stoeckle E; Devouassoux-Shisheborah M; Floquet A; Arnould L; Guyon F; Mishellany F; Garbay D; Cuppens T; Zikan M; Leroux A; Frouin E; Duvillard P; Terrier P; Farre I; Valo I; MacGrogan GM; Chibon F
Mod Pathol; 2015 Jul; 28(7):1001-10. PubMed ID: 25932961
[TBL] [Abstract][Full Text] [Related]
35. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
36. Lung metastases and subsequent malignant transformation of a fumarate hydratase -deficient uterine leiomyoma.
Ahvenainen T; Khamaiseh S; Alkodsi A; Mehine M; Nevala R; Äyräväinen A; Bützow R; Vahteristo P
Exp Mol Pathol; 2022 Jun; 126():104760. PubMed ID: 35367216
[TBL] [Abstract][Full Text] [Related]
37. Analysis of allelic loss as an adjuvant tool in evaluation of malignancy in uterine smooth muscle tumors.
Esposito NN; Hunt JL; Bakker A; Jones MW
Am J Surg Pathol; 2006 Jan; 30(1):97-103. PubMed ID: 16330948
[TBL] [Abstract][Full Text] [Related]
38. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
39. [Uterine smooth muscle tumors: retrospective epidemiological and pathological study of 2760 cases].
Rammeh-Rommani S; Mokni M; Stita W; Trabelsi A; Hamissa S; Sriha B; Tahar-Yacoubi M; Korbi S
J Gynecol Obstet Biol Reprod (Paris); 2005 Oct; 34(6):568-71. PubMed ID: 16208199
[TBL] [Abstract][Full Text] [Related]
40. Molecular prognostication of uterine smooth muscle neoplasms: From CGH array to CINSARC signature and beyond.
Croce S; Chibon F
Genes Chromosomes Cancer; 2021 Mar; 60(3):129-137. PubMed ID: 33099852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
